Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Modular Medical Inc
(NQ:
MODD
)
2.360
-0.010 (-0.42%)
Streaming Delayed Price
Updated: 1:59 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Modular Medical Inc
< Previous
1
2
Next >
Modular Medical Announces Participation at Upcoming Investor Conferences
November 23, 2022
Via
ACCESSWIRE
Modular Medical Provides Product Update
October 03, 2022
Via
ACCESSWIRE
Modular Medical Announces Participation at Upcoming Investor Conferences
September 07, 2022
Via
ACCESSWIRE
Dr. Anne Peters Joins the Modular Medical Advisory Board
August 11, 2022
Via
ACCESSWIRE
Modular Medical Appoints Kevin Schmid as Chief Operating Officer
July 26, 2022
Via
ACCESSWIRE
Modular Medical Appoints Kevin Schmid as Chief Operating Officer
July 26, 2022
Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturing
From
Modular Medical, Inc.
Via
AccessWire
Modular Medical to Present at LD Micro Invitational XII Investor Conference
June 02, 2022
SAN DIEGO, CA / ACCESSWIRE / June 2, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next...
From
Modular Medical, Inc.
Via
AccessWire
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
May 16, 2022
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public...
From
MicroCap Rodeo
Via
AccessWire
Modular Medical to Present at Spring Into Action - Best Ideas Virtual Investor Conference on May 18, 2022
May 12, 2022
SAN DIEGO, CA / ACCESSWIRE / May 12, 2022 / Modular Medical, Inc. ("Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of...
From
Modular Medical, Inc.
Via
AccessWire
Modular Medical Announces $8 Million Registered Direct Offering
May 03, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Modular Medical, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Modular Medical to Present at the Oppenheimer 32nd Annual Healthcare Conference
March 03, 2022
SAN DIEGO, CA / ACCESSWIRE / March 3, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next...
From
Modular Medical, Inc.
Via
AccessWire
Modular Medical Appoints James "Jeb" Besser as Chief Executive Officer
February 24, 2022
Lynn Vos to remain on board of directors Besser brings 25 years of experience in life sciences, technology, capital markets Company reaffirms timeline for 510(k) submission of MODD1 insulin pump to FDA...
From
Modular Medical, Inc.
Via
AccessWire
Exposures
Product Safety
Modular Medical Announces Pricing of $15 Million Public Offering and Uplisting to the Nasdaq Capital Market
February 10, 2022
SAN DIEGO, CA / ACCESSWIRE / February 10, 2022 / Modular Medical, Inc., (NASDAQ:MODD) (the "Company" or "Modular Medical"), a development-stage insulin pump company focused on providing insulin...
From
Modular Medical, Inc.
Via
AccessWire
Steven G. Felsher and Philip B. Sheibley Appointed to Board of Directors of Modular Medical, Inc.
November 29, 2021
SAN DIEGO, CA / ACCESSWIRE / November 29, 2021 / Modular Medical, Inc. (the "Company" or "Modular Medical") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery...
From
Modular Medical, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Modular Medical, Inc. Announces Reverse Stock Split in Connection with Application for Uplisting on the NASDAQ Capital Market
November 26, 2021
SAN DIEGO, CA / ACCESSWIRE / November 26, 2021 / Modular Medical, Inc. (the "Company") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to...
From
Modular Medical, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Modular Medical Expands Executive Team with Appointment Of Lynn O'Connor Vos as New CEO
August 16, 2021
O'Connor Vos Brings Deep Experience in Market Development, Commercializing Products and Patient Advocacy SAN DIEGO, CA / ACCESSWIRE / August 16, 2021 / Modular Medical, Inc. (OTCQB:MODD), a...
From
Modular Medical, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Encode Ideas, L.P. Announces the Initiation of Research Coverage on Modular Medical, Inc.
June 07, 2021
Dover, Delaware--(Newsfile Corp. - June 7, 2021) - Encode Ideas, L.P. Initiates Research on Modular Medical, Inc. (OTCQB: MODD). The...
Via
Newsfile
Modular Medical Welcomes Global Healthcare Leader Lynn Vos to its Board of Directors
May 25, 2021
SAN DIEGO, CA / ACCESSWIRE / May 25, 2021 / Modular Medical, Inc. (OTCQB:MODD), a medical device company focused on next generation insulin delivery technologies to widen the accessibility of insulin...
From
Modular Medical, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Modular Medical Announces Financing
May 12, 2021
SAN DIEGO, CA / ACCESSWIRE / May 12, 2021 / Modular Medical, Inc. (OTCQB:MODD), a medical device company focused on next generation insulin delivery technologies to widen the accessibility of insulin...
From
Modular Medical, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.